Monitor 2026 revenue recognition from the $49.5 million in purchase orders and track commercial deployment progress. The stock may react positively if the company converts these orders into actual revenue, but remains high-risk given current losses and small market cap.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 27 $0.0970entry
- T+1 · 8mo ago −1.03%α −0.67% · $0.0960
- T+5 · 8mo ago +3.09%α −0.77% · $0.1000
- T+20 · 7mo ago −27.84%α −40.58% · $0.0700
- T+60 · 5mo ago −41.24%α −57.30% · $0.0570
Price Chart
How similar events traded
Executive Summary
Inspira Technologies reported minimal 2025 revenue of $289,000 and a net loss of $13.22 million, but secured $49.5 million in binding purchase orders expected to convert to revenue in 2026. The company also raised $4.75 million in gross proceeds post-year-end, ensuring Nasdaq compliance. Clinical deployments and commercial traction for its ART100 system are progressing, though financials remain weak.
Key Facts
- 2025 revenue was $289,000, up from $0 in 2024
- Net loss widened to $13.22 million in 2025 from $11.053 million in 2024
- Secured binding purchase orders totaling $49.5 million, with revenue expected in 2026
- Cash and cash equivalents decreased to $3.159 million as of December 31, 2025, from $5.779 million in 2024
- Completed a registered direct offering post-year-end, generating gross proceeds of $4.75 million
- Company believes it now satisfies Nasdaq's $2.5 million shareholders' equity requirement
- ART100 system deployed at multiple leading U.S. medical centers, including use in lung transplant cases
- Appointed former Johnson & Johnson executive as VP of Global Sales
- Terminated non-binding term sheet with Bio-View Ltd. for acquisition of liquid biopsy business
Financial Impact
Revenue expected to increase significantly in 2026 from $49.5 million in purchase orders, though 2025 revenue was minimal at $289,000. Net loss increased to $13.22 million. Cash position improved by $4.75 million from offering.
Risk Factors
- High cash burn with net loss increasing while revenue remains minimal
- Revenue from $49.5 million in purchase orders is not yet recognized and dependent on procurement processes
- Small market cap ($5M) makes the stock highly volatile and speculative
- Continued reliance on capital raises for survival
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001185185-26-001077 |
| Document: iinn6k032626.htm | 0001185185-26-001077 |
| Document: 0001185185-26-001077-index-headers.html | 0001185185-26-001077 |
| Document: 0001185185-26-001077-index.html | 0001185185-26-001077 |
| Document: 0001185185-26-001077.txt | 0001185185-26-001077 |
Track record
11 reports on IINNW
2 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +213.25% at T+5 after the May 18, 2026 report. 2 of 5 went positive at some point.
Filters
- May 19, 202625w ago 6-K Neutral 4/10 Entry $0.1420 to $0.1200 ▼ −15.49% −16.48% vs SPY
- May 18, 202626w ago 6-K Bullish 6/10 Entry $0.0830 to $0.1310 ▲ +57.83% +56.25% vs SPY
- Apr 16, 202630w ago 6-K Bullish 7/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 16, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 15, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 14, 202630w ago 6-K Neutral 3/10 Entry $0.0720 to $0.0690 ▼ −4.17% −10.46% vs SPY
- Apr 13, 202631w ago 6-K Bullish 7/10 Entry $0.0600 to $0.0690 ▲ +15.00% +7.27% vs SPY
- Apr 6, 202632w ago 6-K Bullish 8/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
- Apr 6, 202632w ago 6-K Bullish 7/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
- Mar 31, 202632w ago 6-K Neutral 4/10 Entry $0.0800 to $0.0690 ▼ −13.75% −23.17% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers